Temporary biventricular support as a bridge to recovery: A justifiable strategy for small children with fulminant

Nur Dikmen Yaman1, Tanıl Kendirli2, Tayfun Uçar3

  • 1Department of Cardiovascular Surgery, Ankara University School of Medicine, Ankara, Turkey.

Perfusion
|April 9, 2021
PubMed

Insights

Mechanical circulatory support (MCS) can save children with acute cardiogenic shock (ACS). A Levitronix CentriMag System provided biventricular support, enabling recovery in a pediatric patient, highlighting its potential for young children.

Area of Science:

  • Pediatric Cardiology
  • Cardiothoracic Surgery
  • Biomedical Engineering

Background:

  • Mechanical circulatory support (MCS) is critical for pediatric acute cardiogenic shock (ACS).
  • Myocardial recovery after MCS is infrequent, with limited options for low-body-weight children.
  • Extracorporeal membrane oxygenation (ECMO) is a common bridge, but may negatively impact myocardial recovery.

Purpose of the Study:

  • To describe the successful use of a Levitronix CentriMag System for biventricular support.
  • To evaluate its efficacy as a bridge to recovery in a pediatric patient with fulminant myocarditis.
  • To highlight the system's potential for infants and small children with ACS.

Main Methods:

  • Case report of a 16-month-old boy (11 kg) with type A influenza-related fulminant myocarditis.
  • Utilized the Levitronix CentriMag System for short-term, biventricular paracorporeal support.
  • Monitored patient's recovery and outcome following biventricular support.

Main Results:

  • The Levitronix CentriMag System provided safe and effective biventricular support.
  • The pediatric patient achieved recovery from acute cardiogenic shock.
  • Demonstrated successful bridging to recovery using this MCS modality.

Conclusions:

  • The Levitronix CentriMag System is a viable option for short-term biventricular support in infants and small children with ACS.
  • This case highlights the potential for myocardial recovery with appropriate MCS strategies.
  • Further research is warranted to explore MCS's role in promoting recovery in pediatric populations.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
48
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
125
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
90
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
85
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
111